Mutational pathways, resistance profile, and side effects of cyanovirin relative to human immunodeficiency virus type 1 strains with N-glycan deletions in their gp120 envelopes

Journal of Virology

Volumn 80, Issue 17, 2006, Pages 8411-8421

  Balzarini, Jan ^a   Van Laethem, Kristel ^a   Peumans, Willy J ^b   Van Damme, Els J M ^b   Bolmstedt, Anders ^c   Gago, Federico ^d   Schols, Dominique ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; CD4 ANTIGEN; CD69 ANTIGEN; CD8 ANTIGEN; CYANOVIRIN N; GLYCOPROTEIN GP 120; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; LECTIN; MANNAN; THYMIDINE; TRITIUM; VIRUS DNA; VIRUS GLYCOPROTEIN;

ANTIGEN EXPRESSION; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; CYTOTOXICITY; GENE MUTATION; GENOTYPE; GLYCOSYLATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MITOGENESIS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; RETROVIRUS; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE; VIRUS CULTURE; VIRUS ENVELOPE; VIRUS ISOLATION; VIRUS RESISTANCE;

BACTERIAL PROTEINS; CARRIER PROTEINS; CELLS, CULTURED; DRUG RESISTANCE, VIRAL; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MODELS, MOLECULAR; MUTATION; POLYSACCHARIDES; SEQUENCE DELETION; T-LYMPHOCYTES;

GALANTHUS NIVALIS; HIPPEASTRUM; HUMAN IMMUNODEFICIENCY VIRUS 1; PROKARYOTA;

EID: 33748650569     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00369-06     Document Type: Article

References (33)

1. Balzarini, J., S. Hatse, K. Vermeire, K. Princen, S. Aquaro, C.-F Perno, E. De Clercq, H. Egberink, G. Vanden Mooter, W. Peumans, E. Van Damme, and D. Schols. 2004. Mannose-specific plant lectins from the Amaryllidaceae family qualify as efficient microbicides for prevention of human immunodeficiency virus infection. Antimicrob. Agents Chemother. 48:3858-3870.
2. Balzarini, J., K. Van Laethem, S. Hatse, K. Vermeire, E. De Clercq, W. Peumans, E. Van Damme, A.-M. Vandamme, A. Bolmstedt, and D. Schols. 2004. Profile of resistance of human immunodeficiency virus to mannose-specific plant lectins. J. Virol. 78:10617-10626.
3. Balzarini, J. 2005. Targeting the glycans of gp120: a novel approach aimed at the Achilles heel of HIV. Lancet Infect. Dis. 5:726-731.
4. Balzarini, J., K. Van Laethem, S. Hatse, M. Froeyen, E. Van Damme, W. Peumans, E. De Clercq, and D. Schols. 2005. Marked depletion of glycosylation sites in HIV-1 gp120 under selection pressure by the mannose-specific plant lectins of Hippeastrum hybrid and Galanthus nivalis. Mol. Pharmacol. 67:1556-1565.
5. Balzarini, J., K. Van Laethem, S. Hatse, M. Froeyen, W. Peumans, E. Van Damme, and D. Schols. 2005. Carbohydrate-binding agents cause deletions of highly conserved glycosylation sites in HIV gp120. A new therapeutic concept to hit the Achilles heel of HIV. J. Biol. Chem. 280:41005-41014.
6. Balzarini, J., K. Van Laethem, S. Hatse, A. Bugatti, M. Rusnati, S. Aquaro, C.-F. Perno, Y. Igarashi, T. Oki, and D. Schols. 2006. Chemotherapy of human immunodeficiency virus by pradimicin A: a novel therapeutic concept for treatment of glycosylated enveloped viruses. Abstr. 19th Int. Conf. Antivir. Res., abstr. 6.
7. Balzarini, J. Large-molecular-weight carbohydrate-binding agents as HIV entry inhibitors targeting glycoprotein gp120. Curr. Opin. HIV AIDS, in press.
8. Bewley, C. A., K. R. Gustafson, M. R. Boyd, D. G. Covell, A. Bax, G. M. Clore, and A. M. Gronenborn. 1998. Solution structure of cyanovirin-N, a potent HIV-inactivating protein. Nat. Struct. Biol. 5:571-578.
9. Bewley, C. A. 2001. Solution structure of a cyanovirin-N:Man alpha 1-2Man alpha complex: structural basis for high-affinity carbohydrate-mediated binding to gp120. Structure 9:931-940.
10. Bewley, C. A., S. Kiyonaka, and I. Hamachi. 2002. Site-specific discrimination by cyanovirin-N for α-linked trisaccharides comprising the three arms of Man(8) and Man(9). J. Mol. Biol. 322:881-889.
11. Bolmstedt, A. J., B. R. O'Keefe, S. R. Shenoy, J. B. McMahon, and M. R. Boyd. 2001. Cyanovirin-N defines a new class of antiviral agent targeting N-linked, high-mannose glycans in an oligosaccharide-specific manner. Mol. Pharmacol. 59:949-954.
12. Botos, I., B. R. O'Keefe, S. R. Shenoy, L. K. Cartner, D. M. Ratner, P. H. Seeberger, M. R. Boyd, and A. Wlodawer. 2002. Structures of the complexes of a potent anti-HIV protein cyanovirin-N and high mannose oligosaccharides. J. Biol. Chem. 277:34336-34342.
13. Boyd, M. R., K. R. Gustafson, J. B. McMahon, R. H. Shoemaker, B. R. O'Keefe, T. Mori, R. J. Gulakowski, L. Wu, M. I. Rivera, C. M. Laurencot, M. J. Currens, J. H. Cardellina II, R. W. Buckheit, Jr, P. L. Nara, L. K. Pannell, R. C. Sowder II, and L. E. Henderson. 1997. Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development. Antimicrob. Agents Chemother. 41:1521-1530.
14. Calarese, D. A, C. N. Scanlan, M. B. Zwick, S. Deechongkit, Y. Mimura, R. Kunert, P. Zhu, M. R. Wormald, R. L. Stanfield, K. H. Roux, J. W. Kelly, P. M. Rudd, R. A. Dwek, H. Katinger, D. R. Buron, and I. A. Wilson. 2003. Antibody domain exchange is an immunological solution to carbohydrate cluster recognition. Science 300:2065-2071.
15. Dwek, R. A., T. D. Butters, F. M. Platt, and N. Zitzmann. 2002. Targetting glycosylation as a therapeutic approach. Nat. Rev. Drug Discov. 1:65-75.
16. Gallaher, W. R., J. M. Ball, R. F. Garry, A. M. Martin-Amedee, and R. C. Montelaro. 1995. A general model for the surface glycoproteins of HIV and other retroviruses. AIDS Res. Hum. Retrovir. 11:191-202.
17. Giomarelli, B., R. Prowedi, F. Meacci, T. Maggi, D. Medaglinl, G. Pozzi, T. Mori, J. B. McMahon, R. Gardella, and M. R. Boyd. 2002. The microbicide cyanovirin-N expressed on the surface of commensal bacterium Streptococcus gordonii captures HIV-1. AIDS 16:1351-1356.
18. Huang, C. C., M. Tang, M. Y. Zhang, S. Majeed, E. Montabana, R. L. Stanfield, D. S. Dimitrov, B. Korber, J. Sodroski, I. A. Wilson, R. Wyatt, and P. D. Kwong. 2005. Structure of a V3-containing HIV-1 gp120 core. Science 310:1025-1028.
19. Kwong, P. D., R. Wyatt, J. Robinson, R. W. Sweet, J. Sodroski, and W. A. Hendrickson. 1998. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393:648-659.
20. Lagenaur, L. A., X. Liu, D. A. Simpson, K. Essenmacher, C. Parker, C.-H. Chang, D. Tsai, S. Rao, D. Hamer, T. P. Parks, P. P. Lee, and Q. Xu. 2005. Development of vaginal lactobacilli for mucosal delivery of a topical microbicide, cyanovirin-N (CV-N). Abstr. Int. Meet. Inst. Hum. Virol., abstr. S93.
21. Leonard, C. K., M. W. Spellman, L. Riddle, R. J. Harris, J. N. Thomas, and T. J. Gregory. 1990. Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. J. Biol. Chem. 265:10373-10382.
22. Mori, T., R. H. Shoemaker, R. J. Gulakowski, B. L. Krepps, J. B. McMahon, K. R. Gustafson, L. K. Pannell, and M. R. Boyd. 1997. Biochem. Biophys. Res. Commun. 238:218-222.
23. Scanlan, C. N., R. Pantophlet, M. R. Wormald, S. E. Ollmann, R. Stanfield, I. A. Wilson, H. Katinger, R. A. Dwek, P. M. Rudd, and D. R. Burton. 2002. The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha 1→2 mannose residues on the outer face of gp120. J. Virol. 76:7306-7321.
24. Sharon, N., and H. Lis (ed.). 2003. Lectins, 2nd ed. Kluwer Academic Publishers, Dordrecht, The Netherlands.
25. Tsai, C. C., P. Emau, Y. Jiang, M. B. Agy, R. J. Shattock, A. Schmidt, W. R. Morton, K. R. Gustafson, and M. R. Boyd. 2004. Cyanovirin-N inhibits AIDS virus infections in vaginal transmission models. AIDS Res. Hum. Retrovir. 20:11-18.
26. Van Damme, E. J. M., A. K. Allen, and W. J. Peumans. 1987. Leaves of the orchid twayblade (Listera ovata) contain a mannose-specific lectin. Plant Physiol. 85:566-569.
27. Van Damme, E. J. M., A. K. Allen, and W. J. Peumans. 1988. Related mannose-specific lectins from different species of the family Amaryllidaceae. Physiol. Plant 73:52-57.
28. Van Damme, E. J. M., W. J. Peumans, A. Pusztai, and S. Bardocz (ed.). 1998. Handbook of plant lectins: properties and biomedical applications. John Wiley & Sons, Chichester, United Kingdom.
29. Van Laethem, K., Y. Schrooten, P. Lemey, E. Van Wijngaerden, S. De Wit, M. Van Ranst, and A.-M. Vandamme. 2005. A genotypic resistance assay for the detection of drug resistance in the human immunodeficiency virus type 1 envelope gene. J. Virol. Methods 123:25-34.
30. 2: structural basis for specificity and high-affinity binding to the core pentasaccharide from N-linked oligomannoside. J. Biol. Chem. 280:29269-29276.
31. Witvrouw, M., V. Fikkert, A. Hantson, C. Pannecouque, B. R. O'Keefe, J. McMahon, L. Stamatatos, E. De Clercq, and A. Bolmstedt. 2005. Resistance of human immunodeficiency virus type 1 to the high-mannose binding agents cyanovirin N and concanavalin A. J. Virol. 79:7777-7784.
32. Wyatt, R., P. D. Kwong, E. Desjardins, R. W. Sweet, J. Robinson, W. A. Hendrickson, and J. G. Sodroski. 1998. The antigenic structure of the HIV gp120 envelope glycoprotein. Nature 393:705-711.
33. Yang, F., C. A. Bewley, J. M. Louis, K. R. Gustafson, M. R. Boyd, A. M. Gronenborn, M. Clore, and A. Wlodawer. 1999. Crystal structure of cyanovirin-N, a potent HIV-inactivating protein, shows unexpected domain swapping. J. Mol. Biol. 288:403-412.